An inflammatory biomarker signature reproducibly predicts CAR-T treatment failure in patients with aggressive lymphoma across the ZUMA trials cohorts Meeting Abstract
| Authors: | Raj, S.; Xie, J.; Fei, T.; Song, Q.; Kim, J. J.; To, C.; van den Brink, M. R. M.; Perales, M. A.; Mattie, M.; Shouval, R. |
| Abstract Title: | An inflammatory biomarker signature reproducibly predicts CAR-T treatment failure in patients with aggressive lymphoma across the ZUMA trials cohorts |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 224 |
| Language: | English |
| ACCESSION: | WOS:001159306700225 |
| DOI: | 10.1182/blood-2023-173798 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
616Van Den Brink -
913Perales -
19Raj -
149Shouval -
40Fei